39 results on '"Sripichai, Orapan"'
Search Results
2. Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE
3. Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells
4. Association between SCN5A and sudden unexplained nocturnal death syndrome in Thai decedents: a case–control study
5. In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes
6. Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells.
7. Impaired Terminal Erythroid Maturation in β0-Thalassemia/HbE Patients with Different Clinical Severity
8. Lysine-Specific Histone Demethylase 1 Inhibition Enhances Robust Fetal Hemoglobin Induction in Human β0-Thalassemia/Hemoglobin E Rrythroid Cells
9. MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
10. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming
11. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
12. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
13. Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE.
14. Impaired Terminal Erythroid Maturation in β 0 -Thalassemia/HbE Patients with Different Clinical Severity.
15. Downregulation of Transcription Factor LRF/ZBTB7A Increases Fetal Hemoglobin Expression in β-Thalassemia/Hemoglobin E Erythroid Cells
16. ZNF802 (JAZF1), a Possible New Therapeutic Target for Treatment of β-Thalassemia
17. A scoring system for the classification of β-thalassemia/Hb E disease severity
18. Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study
19. Comparison of gene expression profiles between human erythroid cells derived from fetal liver and adult peripheral blood
20. Intrinsic Pathophysiological Features of Erythroid Cells Derived From Various Thalassemia Syndromes
21. Histone Modification Levels are Correlated with the Severity of -Thalassemia/Hbe Patients
22. AB045. Molecular markers for disease severity in beta thalassemia/Hb E disease
23. 3071 - Histone Modification Levels are Correlated with the Severity of -Thalassemia/Hbe Patients
24. 3072 - Intrinsic Pathophysiological Features of Erythroid Cells Derived From Various Thalassemia Syndromes
25. Insight into the Peopling of Mainland Southeast Asia from Thai Population Genetic Structure
26. HbF-Inducing Cytokines and BCL11A shRNA Have Combined Effects Upon Globin Gene Reprogramming In Adult Human Erythroblasts
27. Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study
28. Ineffective Erythropoiesis Caused by Phenylhydrazine Activates the Expression of GDF15 in Maturing Erythroblasts.
29. During Terminal Differentiation, HbF-Inducing Cytokines Cause Decreased Expression and Reduced Globin Locus Occupancy of BCL11A in Human Erythroblasts.
30. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
31. Gamma-Globin Gene Expression in Adult Human Erythroblasts Is Associated with Concurrent Changes in the Nuclear Protein Levels of at Least Seven Transcription Factors.
32. Searching for Disease Modifiers Genes in Thalassemia.
33. Genetic Analysis of Candidate Modifier Polymorphisms in β-Thalassemia/Hb E Patients.
34. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E.
35. Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study.
36. Downregulation of Transcription Factor LRF/ZBTB7A Increases Fetal Hemoglobin Expression in ß-Thalassemia/Hemoglobin E Erythroid Cells
37. ZNF802 (JAZF1), a Possible New Therapeutic Target for Treatment of ß-Thalassemia
38. Lysine-specific histone demethylase 1 inhibition enhances robust fetal hemoglobin induction in human β 0 -thalassemia/hemoglobin E erythroid cells.
39. A scoring system for the classification of beta-thalassemia/Hb E disease severity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.